Stay updated on Nivolumab/Ipilimumab/Nintedanib Combo in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab/Ipilimumab/Nintedanib Combo in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab/Ipilimumab/Nintedanib Combo in NSCLC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The revision label on the page was updated from v3.6.4 to v3.6.5, signaling a minor patch. No visible study details or core functionality are affected.
    Difference
    0.0%
    Check dated 2026-08-09T11:06:58.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.3 to v3.6.4, indicating a software update. The underlying study information and user-facing content remain unchanged.
    Difference
    0.0%
    Check dated 2026-07-25T17:49:04.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Footer text now includes Moffitt center branding and a new revision tag (v3.6.3). The old revision tag (v3.6.2) was removed.
    Difference
    0.2%
    Check dated 2026-07-04T13:13:06.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page's revision tag was updated to v3.6.2 from v3.6.0, signaling a new version of the page metadata. This update reflects documentation/version control activity rather than changes to the study data.
    Difference
    0.0%
    Check dated 2026-06-27T06:39:51.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Recruitment status now indicates no participant enrollment; new sections for How to Read a Study Record, Common Questions, and How to Join a Study were added, and the Intervention/Treatment heading was adjusted with a revision note updated to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-13T00:30:49.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The page's revision label updates from v3.5.4 to v3.5.5, indicating a new build/version of the page. This is a minor metadata change that does not alter visible content or functionality.
    Difference
    0.0%
    Check dated 2026-06-05T23:52:05.000Z thumbnail image

Stay in the know with updates to Nivolumab/Ipilimumab/Nintedanib Combo in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab/Ipilimumab/Nintedanib Combo in NSCLC Clinical Trial page.